Published in Gastroenterology on November 01, 1965
Biliary excretion of antibiotics in man. Gut (1968) 2.15
Changes of the smooth endoplasmic reticulum induced by rifampicin in human and guinea-pig hepatocytes. Gut (1971) 1.20
Effect of rifampicin on liver function in man. Gut (1972) 1.04
Sites of competition in the selective hepatic uptake of rifamycin-SV, flavaspidic acid, bilirubin, and bromsulphthalein. Gut (1974) 0.87
Mechanisms and prediction of drug-induced liver disease. Gut (1973) 0.87
Clinical pharmacokinetics of rifampicin. Clin Pharmacokinet (1978) 2.83
Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol (1984) 2.63
Determination of bilirubin UDP-glucuronyl transferase activity in needle-biopsy specimens of human liver. Clin Chim Acta (1970) 2.39
A fluorimetric and enzymatic method for the estimation of serum total bile acids. J Clin Pathol (1970) 2.22
Hepatic bilirubin udp-glucuronyl transferase activity in liver disease and gilbert's syndrome. N Engl J Med (1969) 2.21
Biliary excretion of antibiotics in man. Gut (1968) 2.15
Proposal of an improved score method for the diagnosis of pulmonary tuberculosis in childhood in developing countries. Tuber Lung Dis (1992) 1.77
Pharmacokinetics and metabolism of rifampin in humans. Rev Infect Dis (1983) 1.60
Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease. Gut (1972) 1.57
Idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). A study of 42 families. N Engl J Med (1967) 1.48
An assessment of red cell survival in idiopathic unconjugated hyperbilirubinaemia (Gilbert's syndrome) by the use of radioactive diisopropylfluorophosphate and chromium. Australas Ann Med (1967) 1.46
Effect of bunamiodyl on hepatic uptake of sulfobromophthalein in the rat. Am J Physiol (1966) 1.28
Kinetic studies on rifampicin. I. Serum concentration analysis in subjects treated with different oral doses over a period of two weeks. Chemotherapy (1971) 1.20
Serum bile acids in primary biliary cirrhosis. Gut (1972) 1.18
Multicompartmental analysis of serum, urine and bile concentrations of rifampicin and desacetyl-rifampicin in subjects treated for one week. Pharmacol Res Commun (1978) 1.16
Killing of macrophage-ingested mycobacteria by rifampicin, pyrazinamide, and pyrazinoic acid alone and in combination. Am Rev Respir Dis (1985) 1.14
Can rifampicin use be safely extended? Evidence for non-emergence of resistant strains of Mycobacterium tuberculosis. Lancet (1977) 1.14
The penetration of rifampicin, pyrazinamide, and pyrazinoic acid into mouse macrophages. Am Rev Respir Dis (1985) 1.14
Assessment of the plasma disappearance of cholyl'l14C-glycine as a test of hepatocellular disease. Gut (1977) 1.12
The effect of an intravenous infusion of rifamycin SV on the excretion of bilirubin, bromsulphalein, and indocyanine green in man. Gastroenterology (1965) 1.10
Red cell survival in experimental cholestatic cholestatic jaundice. Br J Haematol (1968) 1.09
Reduction in serum bilirubin by phenobarbital in adult unconjugated hyperhilirubinaemia. Is enzyme induction responsible? Am J Med (1968) 1.06
Urinary and serum octopamine in patients with portal-systemic encephalopathy. Lancet (1975) 1.06
Identification of bile acids in the serum and urine in cholestasis. Evidence for 6alpha-hydroxylation of bile acids in man. Biochem J (1976) 1.05
Study of the excretion in bile and concentration in the gall bladder wall of rifamide. Gut (1966) 1.03
The identification of monoconjugates of bilirubin in bile as amide derivatives. Biochem J (1971) 1.02
Pseudomembranous colitis and rifampicin. Lancet (1980) 1.02
Bile acid profiles of human serum and skin interstitial fluid and their relationship to pruritus studied by gas chromatography-mass spectrometry. Clin Sci (Lond) (1982) 0.99
Kinetic studies on the combination rifampicin-trimethoprim in man. I. Absorption and urinary excretion after administration to healthy volunteers of single doses of the two compounds alone and in combination, and of the combination over a period of 1 week. J Antimicrob Chemother (1976) 0.99
Effect of phenobarbitone on plasma (14C)bilirubin clearance in patients with unconjugated hyperbilirubinaemia. Clin Sci Mol Med (1974) 0.98
Does deconjugation of bilirubin glucuronide occur in obstructive jaundice? Lancet (1968) 0.97
Evidence that rifampicin can be used safely for non-tuberculous diseases. Thorax (1980) 0.94
Effect of dietary composition on the unconjugated hyperbilirubinaemia of Gilbert's syndrome. Gut (1976) 0.94
The isolation and characterization of a bile ductule cell population from normal and bile-duct ligated rat livers. Br J Exp Pathol (1977) 0.92
Assessment of the (14C) aminopyrine breath test in liver disease. Gut (1978) 0.89
Unsaturated monohydroxy bile acids in cholestatic liver disease. Biochem J (1972) 0.89
Human bioavailability studies. Bull Int Union Tuberc Lung Dis (1989) 0.88
Twenty-five years of progress in bilirubin metabolism (1952-77). Gut (1978) 0.88
Enigma of bilirubin conjugation. Gastroenterology (1971) 0.87
Pharmacokinetic studies on antituberculosis regimens in humans. I. Absorption and metabolism of the compounds used in the initial intensive phase of the short-course regimens: single administration study. Am Rev Respir Dis (1985) 0.84
Synthesis of bile acid monosulphates by the isolated perfused rat kidney. Biochem J (1976) 0.84
The effect of secretin on bile flow and bile acid and bilirubin excretion following relief of prolonged bile duct obstruction in the rat. J Hepatol (1987) 0.84
Evidence for renal control of urinary excretion of bile acids and bile acid sulphates in the cholestatic syndrome. Clin Sci Mol Med (1977) 0.83
The role of tubular reabsorption in the renal excretion of bile acids. Biochem J (1977) 0.83
Enzymic oxidation of unconjugated bilirubin by rat liver. Biochem J (1986) 0.83
Interaction of rifampicin with other drugs. Tubercle (1980) 0.83
Pharmacokinetic study on intravenous rifampicin in man. Pharmacol Res Commun (1984) 0.81
Effect of acid-base changes on renal clearance of bile pigments. Clin Sci (1966) 0.81
The influence of diet on unconjugated hyperbilirubinaemia in the Gunn rat. Clin Sci Mol Med (1975) 0.80
Excretion of conjugated bilirubin in the isolated perfused rat kidney. Clin Sci Mol Med (1978) 0.79
The biliary excretion of sulphated and non-sulphated bile acids and bilirubin in patients with external bile drainage. Clin Sci (Lond) (1984) 0.79
Changes in the binding of radioactive conjugated bile salts to serum proteins in cholestatic jaundice. Clin Sci (Lond) (1983) 0.79
Ultrastructural changes in the isolated rat kidney induced by conjugated bilirubin and bile acids. Br J Exp Pathol (1976) 0.78
The effect of 3-sulphation and taurine conjugation on the uptake of chenodeoxycholic acid by rat hepatocytes. Biochim Biophys Acta (1983) 0.78
Hepatic transport of sulfated and nonsulfated bile acids in the rat following relief of bile duct obstruction. Hepatology (1984) 0.78
Short-course chemotherapy of pulmonary tuberculosis: a new approach to drug dosage in the initial intensive phase. Am Rev Respir Dis (1986) 0.78
Enhancement of the urinary excretion of non-sulphated and sulphated radioactive bile acids by sodium acetate in the bile duct obstructed rat. Clin Sci (Lond) (1985) 0.77
Renal excretion of bilirubin by the rat. Am J Physiol (1968) 0.77
Urinary excretion of bile acids in cholestasis: evidence for renal tubular secretion in man. Clin Sci (Lond) (1981) 0.77
Bilirubin metabolism. Gut (1969) 0.77
Effect of fasting and lleal resection on the concentration of deoxycholic acid in rat portal blood. Proc Soc Exp Biol Med (1976) 0.76
Investigation of the role of reactive oxygen species in bilirubin metabolism in the Gunn rat. Biochim Biophys Acta (1995) 0.76
A distinctive pattern of serum bile acid and bilirubin concentrations in benign recurrent intrahepatic cholestasis. Hepatogastroenterology (1981) 0.75
Drug combinations and the bioavailability of rifampicin. Tuber Lung Dis (1992) 0.75
Bilirubin Metabolism. Postgrad Med J (1963) 0.75
Treatment of lymphogranuloma venereum with rifampicin. Br J Vener Dis (1980) 0.75
Proceedings: Kinetics of rifampicin and desacetyl-rifampicin in plasma, bile, and urine in humans and the effect of repeated administrations. Acta Pharm Suec (1974) 0.75
[Rifamycin]. G Ital Chemioter (1984) 0.75
Serum concentrations and biliary excretion of bilirubin during short-term treatment with rifampicin. Tijdschr Gastroenterol (1973) 0.75
Dietary modulation of plasma bilirubin and of hepatic microsomal lipid peroxidation in the Gunn rat. Free Radic Res Commun (1991) 0.75
[Study in chemotherapy of experimental lead poisoning. II. Effect of nicotinic acid on coproporphyrinuria in lead poisoning of rat]. Acta Vitaminol (1967) 0.75
Serum and urine concentrations of rifampicin administered by intravenous infusion in man. Arzneimittelforschung (1977) 0.75
Proceedings: Prolonged survival in the Crigler-Najjar syndrome: ultrastructural and dietary studies. Gut (1974) 0.75
Bilirubin metabolism in cholestasis. Mol Aspects Med (1987) 0.75
[Rifamide and rifamycin SV: some comparative observations on kinetics in man]. Antibiotica (1966) 0.75
Biliary excretion of antibiotics. Tijdschr Gastroenterol (1970) 0.75
Maximal biliary excretion and distribution of rifamycin SV administered by infusion in the rat. Chemotherapy (1965) 0.75
The role of dietary lipid in the regulation of unconjugated hyperbilirubinaemia in Gunn rats. Clin Sci (Lond) (1979) 0.75
Proceedings: An alternative pathway for bile acid metabolism in cholestasis involving 6chi-hydroxylation. Gut (1975) 0.75
Some thoughts on the present status and future prospects of chemotherapy of leprosy based on experience with treating tuberculosis. Int J Lepr Other Mycobact Dis (1981) 0.75
[Activity of rifampicin in the infections of the respiratory tract]. Antibiotica (1968) 0.75
Effect of prolonged bile duct obstruction in the rat on hepatic transport of bilirubin. Clin Sci (Lond) (1985) 0.75
The use of Bond-Elut for the estimation of serum bile pigments bonded covalently to albumin. Biomed Chromatogr (1987) 0.75
[A new semi-synthetic antibiotic (Rifamide) in te therapy of infections of the respiratory system]. Wien Med Wochenschr (1967) 0.75
Hereditary disorders of bilirubin metabolism. Acta Hepatogastroenterol (Stuttg) (1974) 0.75
Some recent advances in bile pigment metabolism in relation to jaundice. Acta Hepatosplenol (1968) 0.75
[Experimental hepatic repercussions of antibiotic therapy]. Rev Int Hepatol (1966) 0.75
Therapeutic activity of diftalone in rheumatoid arthritis: a short-term controlled evaluation. Int J Clin Pharmacol (1974) 0.75
[Method for initial evaluation of the action of antiinflammatory agents in rheumatoid arthritis]. Boll Chim Farm (1972) 0.75
A direct fluoroimmunoassay for conjugated chenodeoxycholic acid using antibody coupling to magnetisable particles. Ann Clin Biochem (1980) 0.75
A 1983 assessment of the value of bile pigment determinations in the diagnosis of jaundice. Postgrad Med J (1983) 0.75
Kinetic studies on rifampicin. III. Effect of phenobarbital on the half-life of the antibiotic. Tijdschr Gastroenterol (1974) 0.75
Proceedings: Bilirubin conjugation and excretion. J Clin Pathol (1974) 0.75
A metabolic and kinetic study on the association rifampicin-isoniazid. Respiration (1971) 0.75
Recurrent intrahepatic jaundice. Clinical and laboratory findings in three siblings. Tijdschr Gastroenterol (1971) 0.75
[Study on the chemotherapy of experimental lead poisoning. 1. Effects of lead poisoning on the tryptophan to nicotinic acid metabolism in the rat]. Acta Vitaminol (1967) 0.75
[Multicompartimental model for the study of drugs with high biliary excretion, used in the study of the kinetics of rifampicin in man]. Boll Chim Farm (1972) 0.75
Rifampicin and the liver. Lancet (1978) 0.75